Linan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Linan Zhang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Yong-Li Wang
Department of Pharmacology Hebei Medical University 361 Zhongshan East Road Shijiazhuang Hebei 050017 China
6 shared publications Chen Xiong
The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang, PR China
2 shared publicationsFang Guo
Department of Pharmacology, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, Hebei 050017, China
2 shared publicationsHuicai Guo
Department of Toxicology, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, Hebei 050017, China
2 shared publications- Huicai Guo
Department of Toxicology, School of Public Health, Hebei Medical University, Shijiazhuang, China
2 shared publications Jian Yin
Department of Pharmacology, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, Hebei 050017, China
2 shared publications
Latest Publications
- 3 October 2012
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 27 (1) , 96-103
Na+‐K+‐ATPase, a potent neuroprotective modulator againstAlzheimer disease
Alzheimer disease (AD) is a neurodegenerative disorder clinically characterized by progressive cognitive and memory dysfunction, which is the most common form of dementia. Although the pathogenesis of neuronal injury inADis not clear, recent evidences suggest thatNa+‐K+‐ATPase plays an important role inAD, and may be a potent neuroprotective modulator againstAD. This review aims to provide readers with an in‐depth understanding ofNa+‐K+‐ATPase inADthrough these modulations of some factors that are as follows, which leads to the change of learning and memory in the process ofAD. The deficiency inNa+,K+‐ATPase α1, α2 and α3 isoform genes induced learning and memory deficits, and α isoform was evidently changed inAD, revealing thatNa+,K+‐ATPase α isoform genes may play an important role inAD. Some factors, such as β‐amyloid, cholinergic and oxidative stress, can modulate learning and memory inADthrough the mondulation ofNa+‐K+‐ATPase activity. Some substances, such asZn, s‐Ethyl cysteine, s‐propyl cysteine, citicoline, rivastigmine, VitE, memantine, tea polyphenol, curcumin, caffeine,Alpinia galanga(L.) fractions, andBacopa monniericould play a role in improving memory performance and exert protective effects againstADby increasing expression or activity ofNa+,K+‐ATPase.
- 3 October 2012
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 27 (1) , 96-103
Na+‐K+‐ATPase, a potent neuroprotective modulator againstAlzheimer disease
Alzheimer disease (AD) is a neurodegenerative disorder clinically characterized by progressive cognitive and memory dysfunction, which is the most common form of dementia. Although the pathogenesis of neuronal injury inADis not clear, recent evidences suggest thatNa+‐K+‐ATPase plays an important role inAD, and may be a potent neuroprotective modulator againstAD. This review aims to provide readers with an in‐depth understanding ofNa+‐K+‐ATPase inADthrough these modulations of some factors that are as follows, which leads to the change of learning and memory in the process ofAD. The deficiency inNa+,K+‐ATPase α1, α2 and α3 isoform genes induced learning and memory deficits, and α isoform was evidently changed inAD, revealing thatNa+,K+‐ATPase α isoform genes may play an important role inAD. Some factors, such as β‐amyloid, cholinergic and oxidative stress, can modulate learning and memory inADthrough the mondulation ofNa+‐K+‐ATPase activity. Some substances, such asZn, s‐Ethyl cysteine, s‐propyl cysteine, citicoline, rivastigmine, VitE, memantine, tea polyphenol, curcumin, caffeine,Alpinia galanga(L.) fractions, andBacopa monniericould play a role in improving memory performance and exert protective effects againstADby increasing expression or activity ofNa+,K+‐ATPase.
- 1 July 2012
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 262 (1) , 32-42
The H1–H2 domain of the α1 isoform of Na+–K+–ATPase is involved in ouabain toxicity in rat ventricular myocytes
- 1 July 2012
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 262 (1) , 32-42
The H1–H2 domain of the α1 isoform of Na+–K+–ATPase is involved in ouabain toxicity in rat ventricular myocytes
- Open Access
- 19 January 2012
- Published by Springer Nature in BMC Neuroscience
- Vol. 13 (1) , 10
Serotonin-mediated modulation of Na+/K+ pump current in rat hippocampal CA1 pyramidal neurons
Background: The aim of this study was to investigate whether serotonin (5-hydroxytryptamine, 5-HT) can modulate Na+/K+pump in rat hippocampal CA1 pyramidal neurons.Results: 5-HT (0.1, 1 mM) showed Na+/K+pump current (Ip) densities of 0.40 ± 0.04, 0.34 ± 0.03 pA/pF contrast to 0.63 ± 0.04 pA/pF of the control of 0.5 mM strophanthidin (Str), demonstrating 5-HT-induced inhibition of Ip in a dose-dependent manner in hippocampal CA1 pyramidal neurons. The effect was partly attenuated by ondasetron, a 5-HT3receptor (5-HT3R) antagonist, not by WAY100635, a 5-HT1AR antagonist, while 1-(3-Chlorophenyl) biguanide hydrochloride (m-CPBG), a 5-HT3R specific agonist, mimicked the effect of 5-HT on Ip.Conclusion: 5-HT inhibits neuronal Na+/K+pump activity via 5-HT3R in rat hippocampal CA1 pyramidal neurons. This discloses novel mechanisms for the function of 5-HT in learning and memory, which may be a useful target to benefit these patients with cognitive disorder.
- 19 January 2012
- Published by Springer Nature in BMC Neuroscience
- Vol. 13 (1) , 10
Open AccessSerotonin-mediated modulation of Na+/K+ pump current in rat hippocampal CA1 pyramidal neurons
Background: The aim of this study was to investigate whether serotonin (5-hydroxytryptamine, 5-HT) can modulate Na+/K+pump in rat hippocampal CA1 pyramidal neurons.Results: 5-HT (0.1, 1 mM) showed Na+/K+pump current (Ip) densities of 0.40 ± 0.04, 0.34 ± 0.03 pA/pF contrast to 0.63 ± 0.04 pA/pF of the control of 0.5 mM strophanthidin (Str), demonstrating 5-HT-induced inhibition of Ip in a dose-dependent manner in hippocampal CA1 pyramidal neurons. The effect was partly attenuated by ondasetron, a 5-HT3receptor (5-HT3R) antagonist, not by WAY100635, a 5-HT1AR antagonist, while 1-(3-Chlorophenyl) biguanide hydrochloride (m-CPBG), a 5-HT3R specific agonist, mimicked the effect of 5-HT on Ip.Conclusion: 5-HT inhibits neuronal Na+/K+pump activity via 5-HT3R in rat hippocampal CA1 pyramidal neurons. This discloses novel mechanisms for the function of 5-HT in learning and memory, which may be a useful target to benefit these patients with cognitive disorder.
- 26 April 2011
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 26 (4) , 503-512
Na+/K+‐ATPase inhibition upregulates NMDA‐evoked currents in rat hippocampal CA1 pyramidal neurons
Na+/K+‐ATPase and N‐methyl‐d‐aspartate (NMDA) receptor in hippocampus play very important roles in the regulation of learning and memory. Here, we showed that dihydroouabain (DHO, 10−5–10−3 m), a Na+/K+‐ATPase inhibitor, significantly potentiated NMDA current in rat hippocampal CA1 pyramidal neurons, which was blocked by PP2 (the selective Src tyrosine kinase inhibitor) and PD‐98059 [the selective inhibitor of the mitogen‐activated protein kinases (MAPK) cascade]. These findings reported here uncover that Src mediates the cross‐talk between Na+/K+‐ATPase and NMDA receptor to transduce the signals from Na+/K+‐ATPase to the MAPK cascade and provide new insights into therapeutic target for deeper understanding of the nature of cognitive disorder.
- 26 April 2011
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 26 (4) , 503-512
Na+/K+‐ATPase inhibition upregulates NMDA‐evoked currents in rat hippocampal CA1 pyramidal neurons
Na+/K+‐ATPase and N‐methyl‐d‐aspartate (NMDA) receptor in hippocampus play very important roles in the regulation of learning and memory. Here, we showed that dihydroouabain (DHO, 10−5–10−3 m), a Na+/K+‐ATPase inhibitor, significantly potentiated NMDA current in rat hippocampal CA1 pyramidal neurons, which was blocked by PP2 (the selective Src tyrosine kinase inhibitor) and PD‐98059 [the selective inhibitor of the mitogen‐activated protein kinases (MAPK) cascade]. These findings reported here uncover that Src mediates the cross‐talk between Na+/K+‐ATPase and NMDA receptor to transduce the signals from Na+/K+‐ATPase to the MAPK cascade and provide new insights into therapeutic target for deeper understanding of the nature of cognitive disorder.
- 9 September 2010
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 32 (7) , 464-468
The Paradox of Dopamine and Angiotensin II-Mediated Na+, K+-ATPase Regulation in Renal Proximal Tubules
Accumulated studies reported that the natruretic dopamine (DA) and the anti-natruretic angiotensin II (Ang II) represent an important mechanism to regulate renal Na+ and water excretion through intracellular secondary messengers to inhibit or activate renal proximal tubule (PT) Na+, K+-ATPase (NKA). The antagonistic actions were mediated by the phosphorylation of different position of NKA α1-subunit and different Pals-associated tight junction protein (PATJ) PDZ domains, the different protein kinase C (PKC) isoforms (PKC-β, PKC-ζ), the common adenylyl cyclase (AC) pathway, and the crosstalk and balance between DA and Ang II to NKA regulation. Besides, Ang II-mediated NKA modulation has bi-phasic effects.
- 9 September 2010
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 32 (7) , 464-468
The Paradox of Dopamine and Angiotensin II-Mediated Na+, K+-ATPase Regulation in Renal Proximal Tubules
Accumulated studies reported that the natruretic dopamine (DA) and the anti-natruretic angiotensin II (Ang II) represent an important mechanism to regulate renal Na+ and water excretion through intracellular secondary messengers to inhibit or activate renal proximal tubule (PT) Na+, K+-ATPase (NKA). The antagonistic actions were mediated by the phosphorylation of different position of NKA α1-subunit and different Pals-associated tight junction protein (PATJ) PDZ domains, the different protein kinase C (PKC) isoforms (PKC-β, PKC-ζ), the common adenylyl cyclase (AC) pathway, and the crosstalk and balance between DA and Ang II to NKA regulation. Besides, Ang II-mediated NKA modulation has bi-phasic effects.
- 28 November 2008
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 22 (6) , 615-621
Na+/K+‐ATPase‐mediated signal transduction and Na+/K+‐ATPase regulation
A number of studies suggest that Na+/K+‐ATPase in caveolae interacts with neighboring membrane proteins and organizes cytosolic cascades of signaling proteins to send messages to intracellular organelles in different tissues, mostly in cardiac myocytes. Low concentration of ouabain binding to Na+/K+‐ATPase activates Src/epidermal growth factor receptor complex to initiate multiple signal pathways, which include PLC/IP3/CICR, PI3K, reactive oxygen species (ROS), PLC/DG/PKC/Raf/MEK/ERK1/2, and Ras/Raf/MEK/ERK1/2 pathways. In cardiac myocytes, the resulting downstream events include the induction of some early response proto‐oncogenes, activation of transcription factors, activator protein‐1, and nuclear factor‐κB, the regulation of a number of cardiac growth‐related genes, and the stimulation of protein synthesis and myocyte hypertrophy and apoptosis. Conversely, several factors acting through signal pathways, such as protein kinases, Ca2+, ROS, etc., can modulate the activity of the Na+/K+‐ATPase.
- 28 November 2008
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 22 (6) , 615-621
Na+/K+‐ATPase‐mediated signal transduction and Na+/K+‐ATPase regulation
A number of studies suggest that Na+/K+‐ATPase in caveolae interacts with neighboring membrane proteins and organizes cytosolic cascades of signaling proteins to send messages to intracellular organelles in different tissues, mostly in cardiac myocytes. Low concentration of ouabain binding to Na+/K+‐ATPase activates Src/epidermal growth factor receptor complex to initiate multiple signal pathways, which include PLC/IP3/CICR, PI3K, reactive oxygen species (ROS), PLC/DG/PKC/Raf/MEK/ERK1/2, and Ras/Raf/MEK/ERK1/2 pathways. In cardiac myocytes, the resulting downstream events include the induction of some early response proto‐oncogenes, activation of transcription factors, activator protein‐1, and nuclear factor‐κB, the regulation of a number of cardiac growth‐related genes, and the stimulation of protein synthesis and myocyte hypertrophy and apoptosis. Conversely, several factors acting through signal pathways, such as protein kinases, Ca2+, ROS, etc., can modulate the activity of the Na+/K+‐ATPase.